Blood and Lymphatic System Myelodysplastic Syndrome

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Myelodysplastic Syndrome Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Myelodysplastic Syndrome Projects
--Celgene Corporation
--Amgen Inc
--Chemgenex Pharmaceuticals Ltd
--Cephalon Inc
--Gemin X Biotechnologies Inc.
--CuraGen Corp
--Johnson & Johnson
--Genzyme Corporation
--MethylGene Inc
--Lorus Therapeutics Inc
--Schering-Plough Corp
--Milkhaus Laboratory, Inc.
--Stragen Pharma S.A
--Scios Inc.
--Telik Inc
--Taiho Pharmaceutical Co., Ltd.
--Vion Pharmaceuticals Inc
--Topotarget A/S

--Top Companies in early stage Myelodysplastic Syndrome Projects
--Bayer Ag
--Celgene Corporation
--Innovive Pharmaceuticals, Inc.
--Nippon Shinyaku Co., Ltd.
--Novartis AG
--Onyx Pharmaceuticals Inc
--Seattle Genetics Inc
--Targa Therapeutics Corp.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View